REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,026 | +320.5% | 10,069 | +273.9% | 0.01% | +233.3% |
| Q1 2023 | $244 | -78.1% | 2,693 | -90.8% | 0.00% | -81.2% |
| Q4 2022 | $1,112 | -99.9% | 29,282 | -27.4% | 0.02% | +45.5% |
| Q3 2022 | $1,013,000 | +105.1% | 40,317 | +712.7% | 0.01% | +120.0% |
| Q1 2021 | $494,000 | -60.3% | 4,961 | -61.1% | 0.01% | -86.1% |
| Q3 2020 | $1,243,000 | +12.3% | 12,767 | +79.8% | 0.04% | +9.1% |
| Q2 2020 | $1,107,000 | +329.1% | 7,099 | +296.4% | 0.03% | +94.1% |
| Q1 2020 | $258,000 | – | 1,791 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |